HUP0401782A2 - Új, vízmentes kristályos gabapentin formák - Google Patents

Új, vízmentes kristályos gabapentin formák

Info

Publication number
HUP0401782A2
HUP0401782A2 HU0401782A HUP0401782A HUP0401782A2 HU P0401782 A2 HUP0401782 A2 HU P0401782A2 HU 0401782 A HU0401782 A HU 0401782A HU P0401782 A HUP0401782 A HU P0401782A HU P0401782 A2 HUP0401782 A2 HU P0401782A2
Authority
HU
Hungary
Prior art keywords
gabapentin
crystalline forms
anhydrous crystalline
new
new anhydrous
Prior art date
Application number
HU0401782A
Other languages
English (en)
Inventor
Linna R. Chen
Suresh R. Babu
Claude Jeffrey Calvitt
Brian Tobias
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of HUP0401782A2 publication Critical patent/HUP0401782A2/hu
Publication of HUP0401782A3 publication Critical patent/HUP0401782A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya új, kristályos, vízmentes A és B gabapentin formaés előállításuk gabapentin monohidrátból. Az új, kritályos formák acelebrális betegségek terápiájában hasznos gyógyszerkészítményekgyártásában előnyt biztosítanak.
HU0401782A 2001-10-09 2002-10-03 New anhydrous crystalline forms of gabapentin HUP0401782A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32837501P 2001-10-09 2001-10-09
US10/256,155 US6800782B2 (en) 2001-10-09 2002-09-25 Anhydrous crystalline forms of gabapentin
PCT/US2002/031706 WO2003031391A1 (en) 2001-10-09 2002-10-03 New anhydrous crystalline forms of gabapentin

Publications (2)

Publication Number Publication Date
HUP0401782A2 true HUP0401782A2 (hu) 2005-10-28
HUP0401782A3 HUP0401782A3 (en) 2006-01-30

Family

ID=26945177

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401782A HUP0401782A3 (en) 2001-10-09 2002-10-03 New anhydrous crystalline forms of gabapentin

Country Status (27)

Country Link
US (1) US6800782B2 (hu)
EP (1) EP1463712A1 (hu)
JP (1) JP2005505594A (hu)
KR (1) KR20050033525A (hu)
CN (1) CN1568305A (hu)
AP (1) AP2004003025A0 (hu)
BG (1) BG108702A (hu)
BR (1) BR0213156A (hu)
CA (1) CA2462331A1 (hu)
CO (1) CO5570697A2 (hu)
CZ (1) CZ2004416A3 (hu)
EA (1) EA006557B1 (hu)
GE (1) GEP20063936B (hu)
HR (1) HRP20040408A2 (hu)
HU (1) HUP0401782A3 (hu)
IL (1) IL161099A0 (hu)
IS (1) IS7195A (hu)
MA (1) MA27072A1 (hu)
MX (1) MXPA04003301A (hu)
NO (1) NO20041370L (hu)
NZ (1) NZ531993A (hu)
OA (1) OA12665A (hu)
PL (1) PL368117A1 (hu)
RS (1) RS28204A (hu)
SK (1) SK1572004A3 (hu)
TN (1) TNSN04055A1 (hu)
WO (1) WO2003031391A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043236A1 (en) * 2003-05-19 2007-02-22 Chandiran Thakashina M Process for preparation of gabapentin
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
WO2004110342A2 (en) * 2003-06-12 2004-12-23 Matrix Laboratories Ltd Novel polymorph of gabapentin and its conversion to gabapentin form-ii
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
ITMI20040579A1 (it) * 2004-03-25 2004-06-25 Zambon Spa Processo di preparazione di gabapentina
WO2010023694A2 (en) * 2008-09-01 2010-03-04 Hikal Ltd Crystalline forms of gabapentin and process thereof
CN104649921B (zh) * 2015-01-14 2016-09-28 天津大学 一种加巴喷丁与己二酸共晶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
JPS62247160A (ja) * 1986-03-31 1987-10-28 Aisin Seiki Co Ltd スタ−リングエンジンの始動装置
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) * 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
IL119890A (en) 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
ES2137137B1 (es) 1998-05-25 2000-08-16 Medichem Sa Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.

Also Published As

Publication number Publication date
TNSN04055A1 (fr) 2006-06-01
NO20041370L (no) 2004-04-01
SK1572004A3 (sk) 2005-03-04
EA006557B1 (ru) 2006-02-24
CA2462331A1 (en) 2003-04-17
JP2005505594A (ja) 2005-02-24
HRP20040408A2 (en) 2004-10-31
NZ531993A (en) 2006-09-29
HUP0401782A3 (en) 2006-01-30
IL161099A0 (en) 2004-08-31
CZ2004416A3 (cs) 2005-03-16
CN1568305A (zh) 2005-01-19
EA200400417A1 (ru) 2004-10-28
MXPA04003301A (es) 2004-07-23
OA12665A (en) 2006-06-19
RS28204A (en) 2006-12-15
IS7195A (is) 2004-03-23
GEP20063936B (en) 2006-10-10
CO5570697A2 (es) 2005-10-31
WO2003031391A1 (en) 2003-04-17
US6800782B2 (en) 2004-10-05
US20030092933A1 (en) 2003-05-15
BG108702A (en) 2005-05-31
PL368117A1 (en) 2005-03-21
BR0213156A (pt) 2004-09-14
KR20050033525A (ko) 2005-04-12
EP1463712A1 (en) 2004-10-06
MA27072A1 (fr) 2004-12-20
AP2004003025A0 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
HUP0400782A2 (hu) Antikolinergikumokon és PDE-IV inhibitorokon alapuló új gyógyszerkészítmények
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
HUP0303996A2 (hu) Vakcinakészítmények
ZA200405029B (en) 17α-Alkyl-17β-oxy-estratrienes and intermediates for the production thereof, and use of said 17α-alkyl-17β-oxy-estratrienes for producing medicaments and pharmaceutical preparations
BRPI0311701B8 (pt) formulação farmacêutica de dosagem multiparticulada revestida com liberação controlada de lamotrigina
HUP0302874A2 (hu) Eljárás risperidon előállítására
NO20063308L (no) Kombinasjon av flupirtin og tramadol
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
SE0102440D0 (sv) New compound
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
HUP0300972A2 (hu) Gatifloxacin-pentahidrát
HUP0401782A2 (hu) Új, vízmentes kristályos gabapentin formák
DE50212646D1 (de) Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung
HUP0303154A2 (hu) Az oxkarbazepin új kristályformái, és az előállításukra szolgáló eljárások
HUP0202324A2 (hu) Prukaloprid orális oldat
HUP0300876A2 (hu) Diklofenaksók alkalmazása égési sérülések helyi kezelésére használható gyógyszerkészítmény előállítására
TW200509945A (en) Agent for treatment of anal disease
DE60322871D1 (de) Thaltende zubereitungen
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
ATE331509T1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
ITRM20010293A1 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees